Monthly Archives: April 2016

BriaCell Announces Non-Brokered Private Placement
April 22, 2016

BriaCell Therapeutics Corp. (TSX VENTURE:BCT)(OTCQB:BCTXF) (“BriaCell”, the “Company”, or “BCT”) announced today that it intends ...

BriaCell Announces Proposed Investment by Leading US Biotech Fund – Company Plans to Seek NASDAQ Uplisting –
April 22, 2016

Berkeley, CA and Vancouver, BC – April 22, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Files a Patent Application to Protect Additional Cancer Vaccines with Genetic Features Thought to Promote Strong Anti-Tumor Activity
April 12, 2016

– Data Presentation at American Association for Cancer Research (AACR) Annual Meeting 2016 – Berkeley, ...

BriaCell Targeting Launch of Its Phase I/II Clinical Trial During Current Quarter
April 5, 2016

BERKELEY, CA and VANCOUVER, BC–(Marketwired – April 05, 2016) – BriaCell Therapeutics Corp. (“BriaCell” or ...

Skip to content